Angiogenesis	0	12	O
in	13	15	O
platelet	16	24	B-Gene_or_gene_product
endothelial	25	36	I-Gene_or_gene_product
cell	37	41	I-Gene_or_gene_product
adhesion	42	50	I-Gene_or_gene_product
molecule	51	59	I-Gene_or_gene_product
-	59	60	I-Gene_or_gene_product
1	60	61	I-Gene_or_gene_product
-	61	62	O
null	62	66	O
mice	67	71	O
.	71	72	O

Platelet	74	82	B-Gene_or_gene_product
endothelial	83	94	I-Gene_or_gene_product
cell	95	99	I-Gene_or_gene_product
adhesion	100	108	I-Gene_or_gene_product
molecule	109	117	I-Gene_or_gene_product
(	118	119	I-Gene_or_gene_product
PECAM	119	124	I-Gene_or_gene_product
)	124	125	I-Gene_or_gene_product
-	125	126	I-Gene_or_gene_product
1	126	127	I-Gene_or_gene_product
has	128	131	O
been	132	136	O
previously	137	147	O
implicated	148	158	O
in	159	161	O
endothelial	162	173	B-Cell
cell	174	178	I-Cell
migration	179	188	O
;	188	189	O
additionally	190	202	O
,	202	203	O
anti	204	208	O
-	208	209	O
PECAM	209	214	B-Gene_or_gene_product
-	214	215	I-Gene_or_gene_product
1	215	216	I-Gene_or_gene_product
antibodies	217	227	O
have	228	232	O
been	233	237	O
shown	238	243	O
to	244	246	O
inhibit	247	254	O
in	255	257	O
vivo	258	262	O
angiogenesis	263	275	O
.	275	276	O

Studies	277	284	O
were	285	289	O
therefore	290	299	O
performed	300	309	O
with	310	314	O
PECAM	315	320	B-Gene_or_gene_product
-	320	321	I-Gene_or_gene_product
1	321	322	I-Gene_or_gene_product
-	322	323	O
null	323	327	O
mice	328	332	O
to	333	335	O
further	336	343	O
define	344	350	O
the	351	354	O
involvement	355	366	O
of	367	369	O
PECAM	370	375	B-Gene_or_gene_product
-	375	376	I-Gene_or_gene_product
1	376	377	I-Gene_or_gene_product
in	378	380	O
blood	381	386	B-Multi-tissue_structure
vessel	387	393	I-Multi-tissue_structure
formation	394	403	O
.	403	404	O

Vascularization	405	420	O
of	421	423	O
subcutaneous	424	436	O
Matrigel	437	445	O
implants	446	454	O
as	455	457	O
well	458	462	O
as	463	465	O
tumor	466	471	B-Pathological_formation
angiogenesis	472	484	O
were	485	489	O
both	490	494	O
inhibited	495	504	O
in	505	507	O
PECAM	508	513	B-Gene_or_gene_product
-	513	514	I-Gene_or_gene_product
1	514	515	I-Gene_or_gene_product
-	515	516	O
null	516	520	O
mice	521	525	O
.	525	526	O

Reciprocal	527	537	O
bone	538	542	B-Multi-tissue_structure
marrow	543	549	I-Multi-tissue_structure
transplants	550	561	O
that	562	566	O
involved	567	575	O
both	576	580	O
wild	581	585	O
-	585	586	O
type	586	590	O
and	591	594	O
PECAM	595	600	B-Gene_or_gene_product
-	600	601	I-Gene_or_gene_product
1	601	602	I-Gene_or_gene_product
-	602	603	O
deficient	603	612	O
mice	613	617	O
revealed	618	626	O
that	627	631	O
the	632	635	O
impaired	636	644	O
angiogenic	645	655	O
response	656	664	O
resulted	665	673	O
from	674	678	O
a	679	680	O
loss	681	685	O
of	686	688	O
endothelial	689	700	B-Cell
,	700	701	O
but	702	705	O
not	706	709	O
leukocyte	710	719	B-Cell
,	719	720	O
PECAM	721	726	B-Gene_or_gene_product
-	726	727	I-Gene_or_gene_product
1	727	728	I-Gene_or_gene_product
.	728	729	O

In	730	732	O
vitro	733	738	O
wound	739	744	O
migration	745	754	O
and	755	758	O
single	759	765	O
-	765	766	O
cell	766	770	B-Cell
motility	771	779	O
by	780	782	O
PECAM	783	788	B-Gene_or_gene_product
-	788	789	I-Gene_or_gene_product
1	789	790	I-Gene_or_gene_product
-	790	791	O
null	791	795	O
endothelial	796	807	O
cells	808	813	O
were	814	818	O
also	819	823	O
compromised	824	835	O
.	835	836	O

In	837	839	O
addition	840	848	O
,	848	849	O
filopodia	850	859	B-Cellular_component
formation	860	869	O
,	869	870	O
a	871	872	O
feature	873	880	O
of	881	883	O
motile	884	890	O
cells	891	896	B-Cell
,	896	897	O
was	898	901	O
inhibited	902	911	O
in	912	914	O
PECAM	915	920	B-Gene_or_gene_product
-	920	921	I-Gene_or_gene_product
1	921	922	I-Gene_or_gene_product
-	922	923	O
null	923	927	O
endothelial	928	939	O
cells	940	945	O
as	946	948	O
well	949	953	O
as	954	956	O
in	957	959	O
human	960	965	B-Organism
endothelial	966	977	B-Cell
cells	978	983	I-Cell
treated	984	991	O
with	992	996	O
either	997	1003	O
anti	1004	1008	O
-	1008	1009	O
PECAM	1009	1014	B-Gene_or_gene_product
-	1014	1015	I-Gene_or_gene_product
1	1015	1016	I-Gene_or_gene_product
antibody	1017	1025	O
or	1026	1028	O
PECAM	1029	1034	B-Gene_or_gene_product
-	1034	1035	I-Gene_or_gene_product
1	1035	1036	I-Gene_or_gene_product
siRNA	1037	1042	O
.	1042	1043	O

Furthermore	1044	1055	O
,	1055	1056	O
the	1057	1060	O
expression	1061	1071	O
of	1072	1074	O
PECAM	1075	1080	B-Gene_or_gene_product
-	1080	1081	I-Gene_or_gene_product
1	1081	1082	I-Gene_or_gene_product
promoted	1083	1091	O
filopodia	1092	1101	B-Cellular_component
formation	1102	1111	O
and	1112	1115	O
increased	1116	1125	O
the	1126	1129	O
protein	1130	1137	O
expression	1138	1148	O
levels	1149	1155	O
of	1156	1158	O
Cdc42	1159	1164	B-Gene_or_gene_product
,	1164	1165	O
a	1166	1167	O
Rho	1168	1171	B-Gene_or_gene_product
GTPase	1172	1178	O
that	1179	1183	O
is	1184	1186	O
known	1187	1192	O
to	1193	1195	O
promote	1196	1203	O
the	1204	1207	O
formation	1208	1217	O
of	1218	1220	O
filopodia	1221	1230	B-Cellular_component
.	1230	1231	O

In	1232	1234	O
the	1235	1238	O
developing	1239	1249	O
retinal	1250	1257	B-Multi-tissue_structure
vasculature	1258	1269	I-Multi-tissue_structure
,	1269	1270	O
numerous	1271	1279	O
,	1279	1280	O
long	1281	1285	B-Cellular_component
filamentous	1286	1297	I-Cellular_component
filopodia	1298	1307	I-Cellular_component
,	1307	1308	O
emanating	1309	1318	O
from	1319	1323	O
endothelial	1324	1335	B-Cell
cells	1336	1341	I-Cell
at	1342	1344	O
the	1345	1348	O
tips	1349	1353	O
of	1354	1356	O
angiogenic	1357	1367	O
sprouts	1368	1375	B-Tissue
,	1375	1376	O
were	1377	1381	O
observed	1382	1390	O
in	1391	1393	O
wild	1394	1398	O
-	1398	1399	O
type	1399	1403	O
animals	1404	1411	O
,	1411	1412	O
but	1413	1416	O
to	1417	1419	O
a	1420	1421	O
lesser	1422	1428	O
extent	1429	1435	O
in	1436	1438	O
the	1439	1442	O
PECAM	1443	1448	B-Gene_or_gene_product
-	1448	1449	I-Gene_or_gene_product
1	1449	1450	I-Gene_or_gene_product
-	1450	1451	O
null	1451	1455	O
mice	1456	1460	O
.	1460	1461	O

Together	1462	1470	O
,	1470	1471	O
these	1472	1477	O
data	1478	1482	O
further	1483	1490	O
establish	1491	1500	O
the	1501	1504	O
involvement	1505	1516	O
of	1517	1519	O
endothelial	1520	1531	O
PECAM	1532	1537	B-Gene_or_gene_product
-	1537	1538	I-Gene_or_gene_product
1	1538	1539	I-Gene_or_gene_product
in	1540	1542	O
angiogenesis	1543	1555	O
and	1556	1559	O
suggest	1560	1567	O
that	1568	1572	O
,	1572	1573	O
in	1574	1576	O
vivo	1577	1581	O
,	1581	1582	O
PECAM	1583	1588	B-Gene_or_gene_product
-	1588	1589	I-Gene_or_gene_product
1	1589	1590	I-Gene_or_gene_product
may	1591	1594	O
stimulate	1595	1604	O
endothelial	1605	1616	B-Cell
cell	1617	1621	I-Cell
motility	1622	1630	O
by	1631	1633	O
promoting	1634	1643	O
the	1644	1647	O
formation	1648	1657	O
of	1658	1660	O
filopodia	1661	1670	B-Cellular_component
.	1670	1671	O

